LRRC15 and glioblastoma: Our LRRC15-RIT approach effectively targeted various cancer models, including models of breast cancer, osteosarcoma, glioblastoma, and colorectal cancer, all representing highly lethal cancers with distinct tumor biology and LRRC15 expression patterns.